Screening Still Matters After HPV Jab

2026-09-17

The sealed screening kit, small enough to disappear on a bathroom shelf, represents the part of cervical-cancer prevention that a jab cannot perform alone. Skipping it is a bad bet. NHS Shropshire, Telford and Wrekin is urging women to attend cervical screening even after HPV vaccination, arguing that protection works best as a paired system rather than a substitute. That is the point.

Vaccines lower risk. HPV vaccines prevent infection from types of human papillomavirus that cause many cervical cancers, but they do not cover every cancer-linked type and cannot undo an infection acquired before immunisation; persistent infection with oncogenic HPV can lead towards malignancy. No clean escape. Screening looks for high-risk HPV in cervical samples, then uses cytology to examine cell changes when indicated. They are different tools. One limits exposure; the other can catch warning signs before cancer develops. The biology resists slogans.

Complacency is the threat. A screening invitation can feel routine or awkward, yet its value lies in finding precancerous cell changes while treatment remains straightforward; vaccination and screening operate at separate points in the disease pathway. Delays can cost. Embarrassment and a packed diary can make postponement seem harmless, though neither changes what screening can find. The local NHS message is blunt: attend when invited, because screening can identify high-risk HPV before symptoms intrude. The kit remains unopened. It asks whether reassurance is ever a reason to leave a warning unread.

Recommendations